Delivery Order SPE2DB20D2104-SPE2DB25FMUNE
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,929.26, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units, with a ceiling value of $6,560.81 and a completion date of June 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages, with a ceiling value of $4,434.96 and a period of performance through May 6, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets, a medication used to treat hypertension. The contract is a firm fixed-price delivery order with a ceiling value of $10,006.35 and a period of performance through July 15, 2024. The contract was not set aside for any specific business...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Telmisartan-HCTZ 40-12.5 mg tablets. The order has a ceiling value of $3,380.26 and a completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has a ceiling value of $9,207.44 and a completion date of July 15, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,851.03, is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. The award was made on January 7, 2025, with an ultimate completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units, with a total ceiling value of $3,091.06. The contract is a firm fixed-price, non-set-aside award with a period of performance ending on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has an ultimate completion date of August 13, 2024 and a ceiling value of $7,760.96. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, under which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in units of 30, with a ceiling value of $1,127.92. The contract is a firm fixed-price delivery order with a performance period extending through June 16, 2025. This order is not set-aside and was competitively awarded. Amerisourcebergen...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMUNEDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has a firm fixed price, a ceiling value of $3,060.64, and a performance period ending on July 2, 2025. The contract is not set aside and is awarded as part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/1/25 |